Will MediBuddy beat Big Players with Big Pockets?

▴ MediBuddy will beat Big Players with Big Pockets?
In total, all the funds raised by MediBuddy since its inception is $67.1 million. E-pharmacy giants like Netmeds have $99 million funds and Pharmeasy $1.2 billion funds.

MediBuddy is your medical pal that provides you access to high-quality healthcare 24x7. Co-founded by Satish Kannan and Enbasekar (IIT Madras alumni), MediBuddy lends you highly skilled doctors, medicines and lab tests that you can gain consultations or bookings within the convenience of your home. It gives you a large network of 90,000 doctors, 7000 hospitals and 3000 diagnostic centres across India. It is spread across 23000 Indian pin-codes which cover 95% of the entire Indian landscape. An estimate claims, MediBuddy caters to the healthcare needs of 3 crore Indians.

Their platform provides online consultancy for 18 specialities like Cardiologist, General Physicist, Paediatrics, Psychiatrist, Neurologist, Dermatologist and more. An estimate claims that one can save up to 60% of consultations. Seeing the linguistic diversity as they are in 22 cities of India, they provide consultations in many Indian languages. 

Last year in June, DocsApp (an online doctor consultation platform) merged with MediBuddy. The merger was made to establish market leadership in the online health space. Both the companies now function under the name of MediBuddy and would create a comprehensive digital healthcare platform. The merger raised $20 million or Rs 150 crores in Series B round. The funding was led by Bessemer Venture Partners, Mitsui Sumitomo Fusian Capital, Beyond Next ventures and Facebook’s angel investors. The combined worth of both the companies is at $164-167 million or Rs 1,190-1,210 crores.

In February 2021, MediBuddy closed its Series B funding round and raised $40 million or Rs 292 crores. They also raised Rs 25 crores from Stride ventures’ venture debt fund. Stride Ventures had kept a target corpus of Rs 1000 crores that would be invested in early to late-stage startups. Stride Ventures had earlier announced in its Fund II to invest Rs 9.6 million and Rs 70 crores. This year in June, MediBuddy had its last funding round of Debt - III for $3.4 million. 

MediBuddy has till now raised $67.1 million. How will a company with so little amount of funds give competition to online healthcare giants like 1mg with their $204.6 million funds, Netmeds with $99 million funds and Pharmeasy - $1.2 billion funds.

Can MediBuddy with its low funds beat the big players with big pockets?

Tags : #medibuddy #satishkannan #enbasekar #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026